Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Aglycosylated IgG variants expressed in bacteria that selectively bind FcγRI potentiate tumor cell killing by monocyte-dendritic cells
Sang Taek Jung, Sai T. Reddy, Tae Hyun Kang, et al.
Proceedings of the National Academy of Sciences (2009) Vol. 107, Iss. 2, pp. 604-609
Open Access | Times Cited: 150

Showing 1-25 of 150 citing articles:

Therapeutic antibodies for autoimmunity and inflammation
Andrew C. Chan, Paul J. Carter
Nature reviews. Immunology (2010) Vol. 10, Iss. 5, pp. 301-316
Closed Access | Times Cited: 800
Maternal Immunological Adaptation During Normal Pregnancy
Bahaa Abu-Raya, Christina Michalski, Manish Sadarangani, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 449
Industrial production of recombinant therapeutics in Escherichia coli and its recent advancements
Chung‐Jr Huang, Henry Lin, Xiaoming Yang
Journal of Industrial Microbiology & Biotechnology (2012) Vol. 39, Iss. 3, pp. 383-399
Open Access | Times Cited: 392
Fc glycans of therapeutic antibodies as critical quality attributes
Dietmar Reusch, Max L. Tejada
Glycobiology (2015) Vol. 25, Iss. 12, pp. 1325-1334
Open Access | Times Cited: 353
An overview of autoantibodies in rheumatoid arthritis
Myrthe A. M. van Delft, T. Huizinga
Journal of Autoimmunity (2020) Vol. 110, pp. 102392-102392
Open Access | Times Cited: 292
The state-of-play and future of antibody therapeutics
Zehra Elgundi, Mouhamad Reslan, Esteban Cruz, et al.
Advanced Drug Delivery Reviews (2016) Vol. 122, pp. 2-19
Closed Access | Times Cited: 288
Anti-citrullinated protein antibodies acquire a pro-inflammatory Fc glycosylation phenotype prior to the onset of rheumatoid arthritis
Yoann Rombouts, Ewoud Ewing, Lotte A van de Stadt, et al.
Annals of the Rheumatic Diseases (2013) Vol. 74, Iss. 1, pp. 234-241
Open Access | Times Cited: 253
Immunoglobulin G (IgG) Fab Glycosylation Analysis Using a New Mass Spectrometric High-throughput Profiling Method Reveals Pregnancy-associated Changes
Albert Bondt, Yoann Rombouts, Maurice H. J. Selman, et al.
Molecular & Cellular Proteomics (2014) Vol. 13, Iss. 11, pp. 3029-3039
Open Access | Times Cited: 241
Chemoenzymatic Conjugation of Toxic Payloads to the Globally Conserved N-Glycan of Native mAbs Provides Homogeneous and Highly Efficacious Antibody–Drug Conjugates
Remon van Geel, Marloes A. Wijdeven, Ryan Heesbeen, et al.
Bioconjugate Chemistry (2015) Vol. 26, Iss. 11, pp. 2233-2242
Open Access | Times Cited: 235
Monovalent antibody design and mechanism of action of onartuzumab, a MET antagonist with anti-tumor activity as a therapeutic agent
Mark Merchant, Xiaolei Ma, Henry R. Maun, et al.
Proceedings of the National Academy of Sciences (2013) Vol. 110, Iss. 32
Open Access | Times Cited: 224
Advances in Antibody Design
Kathryn E. Tiller, Peter M. Tessier
Annual Review of Biomedical Engineering (2015) Vol. 17, Iss. 1, pp. 191-216
Open Access | Times Cited: 219
Glycosylation engineering of therapeutic IgG antibodies: challenges for the safety, functionality and efficacy
Yusuke Mimura, Toshihiko Katoh, Radka Saldova, et al.
Protein & Cell (2017) Vol. 9, Iss. 1, pp. 47-62
Open Access | Times Cited: 191
The history of IgG glycosylation and where we are now
Brian A. Cobb
Glycobiology (2019) Vol. 30, Iss. 4, pp. 202-213
Open Access | Times Cited: 156
Impact of structural modifications of IgG antibodies on effector functions
Timon Damelang, Maximilian Brinkhaus, Thijs L. J. van Osch, et al.
Frontiers in Immunology (2024) Vol. 14
Open Access | Times Cited: 36
Functional Characteristics of the High Affinity IgG Receptor, FcγRI
Cees E. van der Poel, Robbert M. Spaapen, Jan G. J. van de Winkel, et al.
The Journal of Immunology (2011) Vol. 186, Iss. 5, pp. 2699-2704
Open Access | Times Cited: 163
Glycoproteomic Analysis of Antibodies
Gerhild Zauner, Maurice H. J. Selman, Albert Bondt, et al.
Molecular & Cellular Proteomics (2013) Vol. 12, Iss. 4, pp. 856-865
Open Access | Times Cited: 160
Revisiting the Role of Glycosylation in the Structure of Human IgG Fc
M. Jack Borrok, Sang Taek Jung, Tae Hyun Kang, et al.
ACS Chemical Biology (2012) Vol. 7, Iss. 9, pp. 1596-1602
Open Access | Times Cited: 147
Aglycosylated antibodies and antibody fragments produced in a scalable in vitro transcription-translation system
Gang Yin, Eudean D. Garces, Junhao Yang, et al.
mAbs (2012) Vol. 4, Iss. 2, pp. 217-225
Open Access | Times Cited: 141
Production of Secretory and Extracellular N-Linked Glycoproteins inEscherichia coli
Adam C. Fisher, Charles H. Haitjema, Cassandra Guarino, et al.
Applied and Environmental Microbiology (2010) Vol. 77, Iss. 3, pp. 871-881
Open Access | Times Cited: 125
Therapeutic monoclonal antibody N-glycosylation – Structure, function and therapeutic potential
Florian Cymer, Hermann Beck, Adelheid Rohde, et al.
Biologicals (2017) Vol. 52, pp. 1-11
Closed Access | Times Cited: 123
Advances in Therapeutic Fc Engineering – Modulation of IgG-Associated Effector Functions and Serum Half-life
Abhishek Saxena, Donghui Wu
Frontiers in Immunology (2016) Vol. 7
Open Access | Times Cited: 119
Efficient expression of full-length antibodies in the cytoplasm of engineered bacteria
Michael-Paul Robinson, Na Ke, Julie Lobstein, et al.
Nature Communications (2015) Vol. 6, Iss. 1
Open Access | Times Cited: 116
Boosting therapeutic potency of antibodies by taming Fc domain functions
Tae Hyun Kang, Sang Taek Jung
Experimental & Molecular Medicine (2019) Vol. 51, Iss. 11, pp. 1-9
Open Access | Times Cited: 112
Antibody Conjugates with Unnatural Amino Acids
Trevor J. Hallam, Erik D. Wold, Alan F. Wahl, et al.
Molecular Pharmaceutics (2015) Vol. 12, Iss. 6, pp. 1848-1862
Closed Access | Times Cited: 111
Antibody Fc engineering improves frequency and promotes kinetic boosting of serial killing mediated by NK cells
Gabrielle Romain, Vladimir Senyukov, Nicolas Rey-Villamizar, et al.
Blood (2014) Vol. 124, Iss. 22, pp. 3241-3249
Open Access | Times Cited: 95
Page 1 - Next Page

Scroll to top